hsa-miR-203

ncRNA information

ncRNA name

hsa-miR-203

Specific or universal ncRNAs

Specific ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

SIK2

Cancer information

Cancer name

Colorectal Cancer

Cancer site

Colon, Rectum, and Anus

Treatment information

Treatment type

Chemotherapy

Drug

Paclitaxel

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Down

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Overexpression of miR-203 sensitizes paclitaxel-resistant colorectal cancer cells through targeting the salt-inducible kinase 2.

Tissue resource

colon tumor tissues and the corresponding adjacent noncancerous tissues

human normal colon cell lines CCD-18Co

human normal colon cell lines CCD-33Co

Experiment

qRT-PCR,Western blot,Luciferase reporter assay


Institute

China-Japan Union Hospital of Jilin University

American Type Culture Collection

Country

China

USA

Continent

Asia

Amercia